DE3785549T2 - Anxiolytisches praeparat. - Google Patents

Anxiolytisches praeparat.

Info

Publication number
DE3785549T2
DE3785549T2 DE8787309984T DE3785549T DE3785549T2 DE 3785549 T2 DE3785549 T2 DE 3785549T2 DE 8787309984 T DE8787309984 T DE 8787309984T DE 3785549 T DE3785549 T DE 3785549T DE 3785549 T2 DE3785549 T2 DE 3785549T2
Authority
DE
Germany
Prior art keywords
anxiolytic
preparation
anxiolytic preparation
medetomidine
useful
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8787309984T
Other languages
English (en)
Other versions
DE3785549D1 (de
Inventor
Risto Lammintausta
Raimo Virtanen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orion Oyj
Original Assignee
Orion Yhtyma Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtyma Oy filed Critical Orion Yhtyma Oy
Application granted granted Critical
Publication of DE3785549D1 publication Critical patent/DE3785549D1/de
Publication of DE3785549T2 publication Critical patent/DE3785549T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
DE8787309984T 1986-11-11 1987-11-11 Anxiolytisches praeparat. Expired - Lifetime DE3785549T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI864570A FI864570A0 (fi) 1986-11-11 1986-11-11 Terapeutiskt anvaendbar foerening.

Publications (2)

Publication Number Publication Date
DE3785549D1 DE3785549D1 (de) 1993-05-27
DE3785549T2 true DE3785549T2 (de) 1993-09-09

Family

ID=8523472

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787309984T Expired - Lifetime DE3785549T2 (de) 1986-11-11 1987-11-11 Anxiolytisches praeparat.

Country Status (12)

Country Link
US (1) US4783477A (de)
EP (1) EP0270267B1 (de)
JP (1) JPS63135330A (de)
AT (1) ATE88343T1 (de)
AU (1) AU587144B2 (de)
DE (1) DE3785549T2 (de)
DK (1) DK175040B1 (de)
ES (1) ES2054687T3 (de)
FI (1) FI864570A0 (de)
HU (1) HU201472B (de)
IE (1) IE60121B1 (de)
ZA (1) ZA878055B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5344840A (en) * 1988-02-29 1994-09-06 Orion-Yhtyma Oy 4-substituted imidazole derivatives useful in perioperative care
GB2215206B (en) * 1988-02-29 1991-07-03 Farmos Oy 4-substituted imidazole derivatives useful in perioperative care
US5124157A (en) 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
GB9111732D0 (en) * 1991-05-31 1991-07-24 Orion Yhtymae Oy The use of certain salts of medetomidine and its optically active enantiomers to regulate the rate of transdermal administration of the drugs
GB2256135B (en) 1991-05-31 1995-01-18 Orion Yhtymae Oy Transdermal administration of 4-substituted imidazoles
US5457100A (en) * 1991-12-02 1995-10-10 Daniel; David G. Method for treatment of recurrent paroxysmal neuropsychiatric
NZ504667A (en) * 1997-12-04 2003-03-28 Allergan Sales Inc Substituted imidazole derivatives having agonist-like activity at alpha 2B or 2B/2C adrenergic receptors
US7795263B2 (en) * 2008-07-08 2010-09-14 Wildlife Laboratories, Inc. Pharmaceutical combination for and method of anesthetizing and immobilizing non-domesticated mammals
US10780079B2 (en) * 2012-10-15 2020-09-22 Orion Corporation Veterinary method of alleviating noise aversion
TWI645866B (zh) 2013-10-07 2019-01-01 美商帝國製藥美國股份有限公司 右美托咪啶經皮輸送裝置及使用其之方法
RU2648449C2 (ru) 2013-10-07 2018-03-26 ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. Способы и композиции для трансдермальной доставки неседативного количества дексмедетомидина
US20150098997A1 (en) * 2013-10-07 2015-04-09 Teikoku Pharma Usa, Inc. Methods and Compositions for Treating Attention Deficit Hyperactivity Disorder, Anxiety and Insomnia Using Dexmedetomidine Transdermal Compositions
PL3554501T3 (pl) * 2016-12-13 2021-12-06 Orion Corporation Deksmedetomidyna lub medetomidyna do zastosowania w leczeniu lęku separacyjnego u zwierząt towarzyszących

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1560271A (en) * 1977-01-14 1980-02-06 Joullie International Sa Therapeutically useful m-trifluoromethylphenylpiperazine derivatives
US4147872A (en) * 1977-09-13 1979-04-03 Pfizer Inc. 3-[2-Hydroxy-4-(substituted)-phenyl]azacycloalkanes and derivatives thereof as analgesic agents and intermediates therefor
ZA815327B (en) * 1980-08-05 1982-07-28 Hoffmann La Roche Benzazepine derivatives
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
US4575510A (en) * 1983-02-17 1986-03-11 Merrell Dow Pharmaceuticals Inc. Method of alleviating withdrawal symptoms
NZ208554A (en) * 1983-06-23 1987-06-30 American Cyanamid Co (aryl and heteroaryl)-(7-(aryl and heteroaryl)-pyrazolo (1,5-a) pyrimidin-3-yl)-methanone derivatives and pharmaceutical compositions
FI844786A0 (fi) * 1984-12-04 1984-12-04 Farmos Oy Terapeutiskt utnyttjbar foerening.
NL8500047A (nl) * 1985-01-09 1986-08-01 Philips Nv Televisie ontvanger met teletext-decodeerschakeling en paginanummergeheugen.

Also Published As

Publication number Publication date
EP0270267B1 (de) 1993-04-21
US4783477A (en) 1988-11-08
DK496687A (da) 1988-05-12
DK175040B1 (da) 2004-05-10
HU201472B (en) 1990-11-28
IE60121B1 (en) 1994-06-01
JPS63135330A (ja) 1988-06-07
DE3785549D1 (de) 1993-05-27
IE873015L (en) 1988-05-11
HUT45399A (en) 1988-07-28
DK496687D0 (da) 1987-09-22
EP0270267A2 (de) 1988-06-08
ZA878055B (en) 1988-04-26
FI864570A0 (fi) 1986-11-11
ES2054687T3 (es) 1994-08-16
EP0270267A3 (en) 1990-07-04
AU587144B2 (en) 1989-08-03
ATE88343T1 (de) 1993-05-15
AU7826987A (en) 1988-05-12

Similar Documents

Publication Publication Date Title
IT8621411A1 (it) Padiglione smontabile particolarmente per il ricovero temporaneo di persone
DE3785549D1 (de) Anxiolytisches praeparat.
DE3780618T2 (de) Verwendung von buspiron zur verbesserung des kurzzeitgedaechtnisses.
DK322189A (da) Imidazo(1,2-a)-(pyridaziner eller pyraziner) til behandling af sygdomme med relation til knogletab
IT1200852B (it) Procedimento e dispositivo per l'alimentazione di elementida montare
DE3484549D1 (de) (3-amino-1h-pyrazol-4-yl)(aryl)ketone.
FI850781A0 (fi) Foerfarande foer framstaellning av av l-karnitin pao mikrobiologiskt saett.
DK472688D0 (da) Anvendelse af bezafibrat til behandling af diabetes
IT1211197B (it) Pannelli dispositivo per l alimentazione di
BR8704628A (pt) Utilizacao de poliois ou misturas de poliois
ATE92318T1 (de) Isolierung von castanospermin und dessen verwendung als antidiabetisches heilmittel.
ES2076141T3 (es) 5-aril-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
FI873125A0 (fi) Foerfarande foer framstaellning av 5,6-substituerade 2,4-kinazolindiaminer samt nya mellanprodukter.
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
ATE79255T1 (de) Wirkstoffe zur verhuetung von tumormetastasen.
ES2059373T3 (es) Extractos de la especie nerium, sus procedimientos de fabricacion y su utilizacion.
LV10391A (lv) Alkilfosforskabes savienojumu izmantosana psoriazes tipa slimibu arstesanai
DE3863093D1 (de) Sulfosuccinamidsaeuren von polyoxypropylendiaminen und ihre verwendung als emulgatoren.
TR24449A (tr) Tiyazinol tuerevleri hazirlanmalarina mahsus usul v ve fungusid olarak kullanimi
GB8616889D0 (en) Source of power
NO862454D0 (no) Fremgangsmaate for behandling av peroxydblekeavluter.
FI871737A0 (fi) Kraftanlaeggning med foerbraenning i en fluidiserad baedd.
IT8603003V0 (it) Crick martinetto del 2000
DE58901297D1 (de) Noremopamil, seine herstellung und verwendung.
ATA36287A (de) Vorrichtung zur feststoffseitigen kopplung von wanderbettadsorptionsvorrichtungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ORION CORP., ESPOO, FI